Gail Halliday Paediatric Oncologist Newcastle

Gail Halliday Paediatric Oncologist Newcastle: Advancing Care for Young People with Cancer

Gail Halliday Paediatric Oncologist Newcastle is a name synonymous with leadership in paediatric solid tumour care and research. Dr Gail Halliday’s dedication focuses on improving outcomes for Teenagers and Young Adults (TYA) with sarcoma. Her journey began during paediatric oncology training in Newcastle upon Tyne. Here, she combined clinical work with laboratory-based research, exploring new drugs in neuroblastoma through a Master’s in Clinical Research.

Passionate About Sarcoma and TYA Cancer Care

Dr Halliday’s interest in sarcoma and TYA cancer care deepened during her Fellowship at the Hospital for Sick Children and Princess Margaret Hospital in Toronto. These formative experiences shaped her ongoing drive to bring cutting-edge therapies to young people across the UK.

Building a World-Class Oncology Service in Newcastle

Since returning to the NHS in 2016, Dr Halliday has held a Consultant post at the Great North Children’s Hospital. She quickly established herself as a key figure in Newcastle’s oncology service. Working closely with Dr Campbell-Hewson, she has expanded the city’s solid tumour service and strengthened the clinical trial portfolio. Their collaboration ensures patients benefit from the latest research and treatment approaches.

Gail Halliday Paediatric Oncologist Newcastle: Leading Clinical Trials and Research

As a principal investigator on multiple clinical trials, Dr Halliday brings innovative cancer treatments to her patients. Her leadership within the North of England Bone and Soft Tissue Sarcoma MDT and the Children’s Cancer and Leukaemia Group (CCLG) National Sarcoma Advisory Panel reflects her deep expertise and commitment to collaborative care.

Championing New Therapies Across Europe

Dr Halliday serves as TYA lead for the Newcastle Experimental Cancer Medicine Centre (ECMC). She also contributes to the Innovative Therapies in Childhood and Adolescent Cancer (ITCC) committee and the EURO EWING Consortium’s New Ewing Therapeutics Strategy Group. These roles keep her at the forefront of emerging therapies, ensuring patients access the most promising treatments in real-time clinical trials.

A Trusted Leader in Paediatric Oncology

With unwavering focus and strategic vision, Gail Halliday Paediatric Oncologist Newcastle continues to shape the future of paediatric oncology. Her dedication to translational research and international collaboration improves survival and quality of life for children and young adults facing cancer.